Aridis Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Aridis Pharmaceuticals, Inc.‘s stocks are currently a part of 12 hedge funds’ portfolios, which represents 7.11% of the total amount of its stocks outstanding. This makes up a total of 1.25M shares of Aridis Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -67.60% or -2.62M shares fewer. As for the holding position changes, 8.33% (1) of current hedge fund investors increased the number of shares held, 33.33% (4) of current holders sold a part of the shares held, and 25% (3) closed the holdings completely. 4 hedge funds are new holders of Aridis Pharmaceuticals, Inc. stock in Q1 2023, it is 33.33% of total holders.
Hedge funds holding Aridis Pharmaceuticals (Q3 2018 – Q1 2023)
| Q3 2018 | 6 |
|---|---|
| Q4 2018 | 4 |
| Q1 2019 | 4 |
| Q2 2019 | 5 |
| Q3 2019 | 7 |
| Q4 2019 | 5 |
| Q1 2020 | 6 |
| Q2 2020 | 5 |
| Q3 2020 | 6 |
| Q4 2020 | 10 |
| Q1 2021 | 10 |
| Q2 2021 | 12 |
| Q3 2021 | 16 |
| Q4 2021 | 17 |
| Q1 2022 | 20 |
| Q2 2022 | 18 |
| Q3 2022 | 15 |
| Q4 2022 | 16 |
| Q1 2023 | 12 |
Hedge funds changes in Aridis Pharmaceuticals positions (Q3 2018 – Q1 2023)
| Q3 2018 | 6 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2018 | 0 | 1 | 2 | 2 | -1 |
| Q1 2019 | 1 | 0 | 2 | 1 | 0 |
| Q2 2019 | 2 | 1 | 1 | 1 | 0 |
| Q3 2019 | 3 | 1 | 1 | 1 | 1 |
| Q4 2019 | 0 | 1 | 3 | 2 | -1 |
| Q1 2020 | 2 | 1 | 1 | 1 | 1 |
| Q2 2020 | 1 | 2 | 0 | 2 | 0 |
| Q3 2020 | 1 | 3 | 1 | 0 | 1 |
| Q4 2020 | 5 | 2 | 1 | 1 | 1 |
| Q1 2021 | 3 | 5 | 1 | 3 | -2 |
| Q2 2021 | 3 | 5 | 1 | 1 | 2 |
| Q3 2021 | 7 | 4 | 1 | 3 | 1 |
| Q4 2021 | 7 | 5 | 0 | 6 | -1 |
| Q1 2022 | 6 | 5 | 2 | 3 | 4 |
| Q2 2022 | 3 | 4 | 5 | 5 | 1 |
| Q3 2022 | 1 | 5 | 4 | 2 | 3 |
| Q4 2022 | 3 | 5 | 4 | 1 | 3 |
| Q1 2023 | 4 | 1 | 4 | 3 | 0 |
Hedge funds changes in Aridis Pharmaceuticals stock options (Q3 2018 – Q1 2023)
| Q3 2018 | 0 | 0 |
|---|---|---|
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 6,000 | 164,000 |
| Q1 2022 | 0 | 0 |
| Q2 2022 | 11,000 | 0 |
| Q3 2022 | 11,000 | 0 |
| Q4 2022 | 6,254 | 0 |
| Q1 2023 | 2,098,000 | 0 |
Top 50 hedge fund holders of Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| COMMONWEALTH EQUITY SERVICES, LLC | 527K | 567.2K | 0.001% |
| VANGUARD GROUP INC | 488K | 524.12K | 0.000% |
| ROUMELL ASSET MANAGEMENT, LLC | 415K | 446.58K | 0.898% |
| GEODE CAPITAL MANAGEMENT, LLC | 126K | 136.02K | 0.000% |
| CITADEL ADVISORS LLC Ken Griffin | 51K | 54.38K | 0.000% |
| EP WEALTH ADVISORS, LLC | 47K | 50K | 0.001% |
| STATE STREET CORP | 40K | 43.24K | 0.000% |
| NORTHERN TRUST CORP | 26K | 28.10K | 0.000% |
| GROUP ONE TRADING, L.P. | 17K | 18.49K | 0.000% |
| BLACKROCK INC. Larry Fink | 16K | 17.44K | 0.000% |
| WEALTH ARCHITECTS, LLC | 13K | 14.07K | 0.003% |
| CITADEL ADVISORS LLC Ken Griffin | 11K | 11.8K | 0.000% |
| SIMPLEX TRADING, LLC | 11K | 11.87K | 0.000% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 10K | 10.66K | 0.000% |
| UBS GROUP AG | 3K | 3.19K | 0.000% |
| WELLS FARGO & COMPANY/MN | 1K | 925 | 0.000% |
| RENAISSANCE TECHNOLOGIES LLC Jim Simons | 0 | 0 | 0.000% |
| CUTLER GROUP LLC / CA | 0 | 0 | 0.000% |